Tai-jan S. Chiu
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Response to comment on "Considering the unmeasured impact of 5-fluorouracil dose intensity in the interpretation of optimal initial relative dose intensity of modified FOLFIRINOX".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 10, 2026
Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 03, 2026
Longitudinal Trajectories of Hematologic Inflammatory Markers and Their Prognostic and Mediating Roles in Nasopharyngeal Carcinoma: A Multi-institutional Cohort Study.
Journal: Clinical and experimental otorhinolaryngology
Published: March 23, 2026
SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217).
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 18, 2025
Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: June 08, 2025
Survival impact of radiotherapy for patients with de novo metastatic rectal cancer.
Journal: Annals of coloproctology
Published: May 15, 2025
Third-line platinum-based chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: April 29, 2025
Validation of a Prognostic Nomogram for Patients with Metastatic Pancreatic Cancer Treated with Nanoliposomal Irinotecan as Second-Line Therapy.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: April 11, 2025
Optimal cutpoint of preoperative neutrophil-lymphocyte ratio and associated postoperative prognosis in colorectal cancer patients.
Journal: International journal of colorectal disease
Published: February 16, 2025
Outcomes of Liposomal Irinotecan With 5-FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance Status.
Journal: Cancer diagnosis & prognosis
Published: January 08, 2025
Last Updated: 09/26/2026